IHC Gastric Cancer Chemotherapy Response, Prognoses Predicted With Blood-Based Immune Proteomics By analyzing blood serum proteomics alongside gastric tumors' omics profiles, researchers found immune features coinciding with treatment response and survival. NeoGenomics, ImmunoGen Ink Testing Deal for Newly Approved Folate Receptor Drug The pharma firm will cover the cost for eligible ovarian cancer patients to be tested using the companion diagnostic to its new drug Elahere. Immunotherapy Response Features Identified in Pancreatic Cancer Microenvironment Researchers compared tumor microenvironment features in pancreatic ductal adenocarcinoma cases receiving an allogeneic vaccine with or without anti-PD-1 treatment. Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders Premium The firm is aiming to commercialize its OncoPrism assay in 2023 as a laboratory-developed test to identify head and neck cancer patients eligible for checkpoint inhibitors. Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients Premium Studies at ESMO showed the importance of repeat biomarker testing to guide treatment after resistance to AstraZeneca's Tagrisso, but tissue-based testing remains a hindrance. Aug 8, 2022 CAP Weighs in on dMMR, MSI Assays for Immunotherapy Patient Selection Premium Jul 12, 2022 NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling Jun 9, 2022 Tempus, Lilly Ink Partnership to Offer No-Cost NGS for Advanced NSCLC Patients Apr 19, 2022 Breast Cancer Clues Revealed by Recurrent Tumor Microenvironment Structures Dec 23, 2021 Multiomic Profiling Uncovers Predictors of Melanoma Response to Immunotherapy Aug 20, 2021 Labcorp, CCORN Ink Partnership to Address Precision Oncology Disparities Jun 4, 2021 Akoya Biosciences, AstraZeneca Collaborate on Spatial Biomarker Profiling for Immuno-Oncology Jan 26, 2021 Researchers ID Four Small Cell Lung Cancer Subtypes, Suggest Future Treatment Implications Premium Dec 2, 2020 Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement Premium Nov 18, 2020 Indivumed, Ultivue Sign Deal to Integrate Cancer Tissue Analysis Technologies Nov 13, 2020 FDA Approves Merck's Keytruda, Agilent CDx in PD-L1-High Triple-Negative Breast Cancer Sep 20, 2020 HPV, p16 May Offer Different Prognostic Clues in Oropharyngeal Cancer, ESMO Data Reveals Premium Jul 22, 2020 Ultivue, OracleBio Collaborate on Tissue Biomarker Analysis Workflow May 29, 2020 Tumor Microbiome Appears to Vary With Cancer Type Feb 25, 2020 10x Genomics Unveils 2020 New Product Pipeline at AGBT Premium Feb 19, 2020 10x Genomics Previews New Product Lineup Ahead of AGBT Premium Nov 5, 2019 Discovery Life Sciences Acquires QualTek Molecular Laboratories Oct 31, 2019 HER2 Amplification Confers Drug Sensitivity Across Tumor Types in New Study Premium Sep 30, 2019 Tempus Finds Tumor-Normal Sequencing, RNA Profiling Aid Patient Matching to Therapies, Trials Aug 8, 2019 Researchers Propose Role For Microbes in Pancreatic Cancer Immune Features, Survival Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.